Who Supplies Irinotecan? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Irinotecan exports, with 164+ registered manufacturers shipping to buyers across 111+ countries — yet a handful of companies dominate the shipments. FRESENIUS KABI ONCOLOGY LIMITED holds the largest share at 13.4% (export value: $5.5M). Close behind, EUGIA PHARMA SPECIALITIES LIMITED (10.3%, $4.2M). INTAS PHARMACEUTICALS LIMITED (9.1%, $3.7M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Irinotecan? Top Manufacturers & Their Buyers
Flow of Irinotecan from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Irinotecan Supplier Network — Key Market Intelligence
The Irinotecan export market from India is led by FRESENIUS KABI ONCOLOGY LIMITED, which alone commands a 13.4% share, shipping $5.5M worth of product across 670 shipments. The second-largest exporter, EUGIA PHARMA SPECIALITIES LIMITED, contributes $4.2M (10.3%) to the overall market. Combined, the top two suppliers alone account for 23.7% of all Irinotecan exports, indicating a relatively concentrated supply base.
Across all 164 tracked manufacturers, the total Irinotecan export value stands at $41.1M from 2.9K shipments. The market average shipment value is $14.2K. The single largest buyer relationship in terms of trade value is FRESENIUS KABI DEUTSCHLAND GMBH, receiving $4.9M worth of product.
The combined buyer network spans 21 named purchasing companies, including FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI THAIL, FRESENIUS KABI CHILE, FRESENIUS KABI COLOM, ZUELLIG PHARMA VIETN and 16 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1FRESENIUS KABI ONCOLOGY LIMITED
FRESENIUS KABI ONCOLOGY LIMITED is the first-largest Irinotecan exporter from India, with a market share of 13.4% and a total export value of $5.5M across 670 shipments. Their average shipment value of $8.2K is below the market average of $14.2K, reflecting a high-volume, competitive pricing strategy.
FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. FRESENIUS KABI DEUTSCHLAND GMBH is the dominant customer, accounting for 88.7% of this supplier's tracked business. Top customers include:
• FRESENIUS KABI DEUTSCHLAND GMBH — $4.9M across 594 shipments (88.7% of this supplier's total exports)
• FRESENIUS KABI THAIL — $169.6K across 21 shipments (3.1% of this supplier's total exports)
• FRESENIUS KABI CHILE — $158.8K across 19 shipments (2.9% of this supplier's total exports)
• FRESENIUS KABI COLOM — $152.0K across 19 shipments (2.8% of this supplier's total exports)
• ZUELLIG PHARMA VIETN — $142.2K across 17 shipments (2.6% of this supplier's total exports)
Key Insight: FRESENIUS KABI ONCOLOGY LIMITED operates with high shipment frequency (670 shipments) at a per-shipment value of $8.2K, indicating a broad distribution network with many smaller, regular orders.
2EUGIA PHARMA SPECIALITIES LIMITED
EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Irinotecan exporter from India, with a market share of 10.3% and a total export value of $4.2M across 88 shipments. Their average shipment value of $48.1K is above the market average of $14.2K, suggesting premium or bulk contract pricing.
EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• EUGIA PHARMA INC — $2.0M across 42 shipments (47.2% of this supplier's total exports)
• EUGIA US LLC — $1.1M across 23 shipments (26.2% of this supplier's total exports)
• EUGIA US LLC — $528.8K across 11 shipments (12.5% of this supplier's total exports)
• EUGIA PHARMA (MALTA) — $391.0K across 8 shipments (9.2% of this supplier's total exports)
• EUGIA PHARMA INC — $204.1K across 4 shipments (4.8% of this supplier's total exports)
Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $48.1K is 240% above the market average of $14.2K, consistent with large-order contracts or value-added formulations.
3INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the third-largest Irinotecan exporter from India, with a market share of 9.1% and a total export value of $3.7M across 1.1K shipments. Their average shipment value of $3.4K is below the market average of $14.2K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ALLOGA FRANCE — $1.0M across 300 shipments (27.3% of this supplier's total exports)
• TO THE ORDER — $917.5K across 269 shipments (24.5% of this supplier's total exports)
• ACCORD HEALTHCARE C/O QESTMED — $656.8K across 193 shipments (17.5% of this supplier's total exports)
• ACCORD HEALTHCARE POLSKA SP Z O O — $587.7K across 172 shipments (15.7% of this supplier's total exports)
• ACCORD HEALTHCARE POLSKA SP Z O O — $563.5K across 165 shipments (15.0% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (1.1K shipments) at a per-shipment value of $3.4K, indicating a broad distribution network with many smaller, regular orders.
4SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fourth-largest Irinotecan exporter from India, with a market share of 5.6% and a total export value of $2.3M across 92 shipments. Their average shipment value of $25.2K is above the market average of $14.2K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 83.1% of this supplier's tracked business. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM — $1.9M across 76 shipments (83.1% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM — $149.4K across 6 shipments (6.4% of this supplier's total exports)
• M/S. SUN PHARMACEUTI — $135.4K across 5 shipments (5.8% of this supplier's total exports)
• SUN PHARMACEUTICALS — $53.9K across 2 shipments (2.3% of this supplier's total exports)
• MSSUN PHARMACEUTICAL — $52.6K across 2 shipments (2.3% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $25.2K is 78% above the market average of $14.2K, consistent with large-order contracts or value-added formulations.
5VENUS REMEDIES LIMITED
VENUS REMEDIES LIMITED is the fifth-largest Irinotecan exporter from India, with a market share of 1.0% and a total export value of $413.5K across 110 shipments. Their average shipment value of $3.8K is below the market average of $14.2K, reflecting a high-volume, competitive pricing strategy.
VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• C M C L — $153.3K across 41 shipments (37.1% of this supplier's total exports)
• U S B — $69.1K across 18 shipments (16.7% of this supplier's total exports)
• PT M L — $66.4K across 18 shipments (16.1% of this supplier's total exports)
• C M C L COSMA MEDICA — $63.6K across 17 shipments (15.4% of this supplier's total exports)
• M.E.L.S.B — $61.1K across 16 shipments (14.8% of this supplier's total exports)
Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (110 shipments) at a per-shipment value of $3.8K, indicating a broad distribution network with many smaller, regular orders.
6ACCURE LABS PRIVATE LIMITED
ACCURE LABS PRIVATE LIMITED is the fifth-largest Irinotecan exporter from India, with a market share of 0.9% and a total export value of $352.4K across 20 shipments. Their average shipment value of $17.6K is above the market average of $14.2K, suggesting premium or bulk contract pricing.
ACCURE LABS PRIVATE LIMITED serves 1 named buyer in our database. PHARMACIE CENTRALE DES HOPITAUX is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• PHARMACIE CENTRALE DES HOPITAUX — $352.4K across 20 shipments (100.0% of this supplier's total exports)
Key Insight: ACCURE LABS PRIVATE LIMITED's per-shipment value of $17.6K is 24% above the market average of $14.2K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Irinotecan Flows
Once Irinotecan leaves the manufacturing plants of companies like FRESENIUS KABI ONCOLOGY LIMITED and EUGIA PHARMA SPECIALITIES LIMITED, it travels to 5 destination markets with a combined import value of $41.1M. Germany absorbs the largest share at 19.7% ($8.1M), followed by Poland (10.7%) and Netherlands (8.3%).
In Germany — the top destination — named importers include FRESENIUS KABI DEUTSCHLAND GMBH. In Poland, key buyers are ACCORD HEALTHCARE POLSKA SP. Z.O.O., ACCORD HEALTHCARE POLSKA SP. Z O.O., ACCORD HEALTHCARE POLSKA SP Z O O.
This geographic spread reflects Irinotecan's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Irinotecan Go? Top Importing Countries & Their Buyers
Trade flow of Irinotecan exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Germany
Germany ranks as the first-largest destination for Irinotecan imports from India, with a total trade value of $8.1M across 452 shipments — representing a 19.7% share of all Irinotecan exports. The average shipment value of $17.9K is above the global average of $14.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Irinotecan importers in Germany: FRESENIUS KABI DEUTSCHLAND GMBH is the largest buyer, accounting for 99.6% ($8.1M) of this market's total imports.
• FRESENIUS KABI DEUTSCHLAND GMBH — $8.1M (99.6% of Germany's total)
Key Insight: Germany's per-shipment average of $17.9K (27% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Irinotecan imports from India.
2Poland
Poland ranks as the second-largest destination for Irinotecan imports from India, with a total trade value of $4.4M across 131 shipments — representing a 10.7% share of all Irinotecan exports. The average shipment value of $33.5K is above the global average of $14.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Irinotecan importers in Poland: ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the largest buyer, accounting for 33.4% ($1.5M) of this market's total imports.
• ACCORD HEALTHCARE POLSKA SP. Z.O.O. — $1.5M (33.4% of Poland's total)
• ACCORD HEALTHCARE POLSKA SP. Z O.O. — $1.3M (28.6% of Poland's total)
• ACCORD HEALTHCARE POLSKA SP Z O O — $563.5K (12.8% of Poland's total)
Key Insight: Poland's per-shipment average of $33.5K (136% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Poland is a key market for Irinotecan imports from India.
3Netherlands
Netherlands ranks as the third-largest destination for Irinotecan imports from India, with a total trade value of $3.4M across 116 shipments — representing a 8.3% share of all Irinotecan exports. The average shipment value of $29.6K is above the global average of $14.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Irinotecan importers in Netherlands: ALLOGA FRANCE is the largest buyer, accounting for 71.1% ($2.4M) of this market's total imports.
• ALLOGA FRANCE — $2.4M (71.1% of Netherlands's total)
• BROCACEF NL : HUB — $744.9K (21.7% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $29.6K (109% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Irinotecan imports from India.
4Belgium
Belgium ranks as the fourth-largest destination for Irinotecan imports from India, with a total trade value of $3.0M across 78 shipments — representing a 7.3% share of all Irinotecan exports. The average shipment value of $38.4K is above the global average of $14.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Irinotecan importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 92.4% ($2.8M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $2.8M (92.4% of Belgium's total)
Key Insight: Belgium's per-shipment average of $38.4K (171% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Irinotecan imports from India.
5Canada
Canada ranks as the fifth-largest destination for Irinotecan imports from India, with a total trade value of $2.9M across 21 shipments — representing a 7.1% share of all Irinotecan exports. The average shipment value of $138.8K is above the global average of $14.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Irinotecan importers in Canada: EUGIA PHARMA INC is the largest buyer, accounting for 68.6% ($2.0M) of this market's total imports.
• EUGIA PHARMA INC — $2.0M (68.6% of Canada's total)
• ACCORD HEALTHCARE INC — $430.7K (14.8% of Canada's total)
Key Insight: Canada's per-shipment average of $138.8K (880% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Irinotecan imports from India.
People Also Ask — Irinotecan Supplier & Trade Network
Who are the top suppliers of Irinotecan from India?+
Which companies buy Irinotecan from Indian manufacturers?+
Where does Irinotecan exported from India go?+
What is the market share of the top Irinotecan supplier from India?+
What is the average shipment value for Irinotecan exports from India?+
Is Irinotecan manufactured in India and exported globally?+
Which country imports the most Irinotecan from India?+
Who are the buyers of Irinotecan in Poland?+
How concentrated is the Irinotecan supplier market in India?+
How do I find verified buyers for Irinotecan in specific countries?+
Irinotecan Trade Network — Key Takeaways
- 1FRESENIUS KABI ONCOLOGY LIMITED is India's dominant Irinotecan exporter with a 13.4% market share and $5.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 164 suppliers collectively account for 40.3% of all tracked Irinotecan exports, with a combined trade value of $41.1M.
- 3Germany is the largest destination market, absorbing 19.7% of India's Irinotecan exports ($8.1M). Poland (10.7%) and Netherlands (8.3%) follow.
- 4With 2.9K total shipments averaging $14.2K each, the Irinotecan export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI THAIL, EUGIA PHARMA INC, EUGIA US LLC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 111 countries
Network value: $41.1M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Irinotecan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Irinotecan.
- 2.Flow Mapping: 164 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,905 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 111 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,905 Verified Shipments
164 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists